Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.48 -0.19 (-4.07%)
At close: Oct 1, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Long-Term Investments (2011 - 2026)

Updated

Oramed Pharmaceuticals (ORMP) reported Long-Term Investments of $199.31 million for Q2 2026, up 349.9% from $44.3 million a year earlier and up 94.8% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Long-Term Investments (2011 - 2026) Analysis & Trends

At the end of FY2025, Oramed Pharmaceuticals posted Long-Term Investments of $71.62 million, up 105.8% from FY2024.

  • Long-Term Investments has a five-year compound annual growth rate of 78.7% (FY2020 to FY2025).
  • By year, Long-Term Investments came in at $34.81 million in FY2024 (-68.4%), $110.19 million in FY2023, $2.7 million in FY2022 (-89.2%) and $25.09 million in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Long-Term Investments in data going back to Q4 2011.
  • Year over year, Long-Term Investments has now increased in each of the last three quarters, with growth averaging 101.5% over the last six quarters.
  • The high point for year-over-year Long-Term Investments in five years was Q1 2024 (growth of 623.9%); the low point was Q1 2023 (a decline of 89.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $102.3 million (Q1 2026), $71.62 million (Q4 2025) and $64.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Oramed Pharmaceuticals 192.94 Mn 192.94 Mn - 199.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 199.31 Mn
Mar 31, 2026 102.30 Mn
Dec 31, 2025 71.62 Mn
Sep 30, 2025 64.80 Mn
Jun 30, 2025 44.30 Mn
Mar 31, 2025 29.72 Mn
Dec 31, 2024 34.81 Mn
Sep 30, 2024 646,000.00
Jun 30, 2024 2.35 Mn
Mar 31, 2024 19.54 Mn
Dec 31, 2023 110.19 Mn
Sep 30, 2023 2.54 Mn
Jun 30, 2023 3.52 Mn
Mar 31, 2023 2.70 Mn
Dec 31, 2022 2.70 Mn
Sep 30, 2022 2.70 Mn
Jun 30, 2022 25.21 Mn
Mar 31, 2022 25.15 Mn
Nov 30, 2021 25.07 Mn
Aug 31, 2021 25.02 Mn
API Access

Oramed Pharmaceuticals Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ORMP&period=max&api_key=YOUR_API_KEY